| Literature DB >> 18486283 |
Ruth H Florese1, Roger W Wiseman, David Venzon, Julie A Karl, Thorsten Demberg, Kay Larsen, Leon Flanary, V S Kalyanaraman, Ranajit Pal, Fausto Titti, L Jean Patterson, Megan J Heath, David H O'Connor, Aurelio Cafaro, Barbara Ensoli, Marjorie Robert-Guroff.
Abstract
Protection afforded by HIV Tat-based vaccines has differed in Indian rhesus and Mauritian cynomolgus macaques. We evaluated native Tat and Ad-HIVtat priming/Tat-boosting regimens in both species. Both vaccines were immunogenic. Only the Ad-tat regimen modestly reduced acute viremia in rhesus macaques after SHIV(89.6P) challenge. Confounding variables uncovered in Mauritian macaques included significant associations of susceptibility to infection with MHC class IB and class II H2 and H5 haplotypes, and resistance to infection with class IB haplotypes H3 and H6. Although protection here was limited, Tat-based vaccines incorporating other HIV components have shown greater efficacy. Combination strategies should be further explored.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18486283 PMCID: PMC2577850 DOI: 10.1016/j.vaccine.2008.03.100
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641